Logo image of INTS

INTENSITY THERAPEUTICS INC (INTS) Stock Earnings & Estimates

NASDAQ:INTS - US45828J1034 - Common Stock

0.282 USD
-0.01 (-3.09%)
Last: 8/29/2025, 8:00:02 PM
0.2801 USD
0 (-0.67%)
After Hours: 8/29/2025, 8:00:02 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032
Revenue
YoY % growth
INTS revenue by date.INTS revenue by date.
N/AN/AN/AN/AN/AN/A
102.00%		N/A
51.50%		N/A
34.58%
EBITDA
YoY % growth
INTS ebitda by date.INTS ebitda by date.
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
INTS ebit by date.INTS ebit by date.
-6.223M-8.014M
-28.77%		-7.55M
5.79%		-8.319M
-10.19%		-16.585M
-99.36%		N/A
24.60%		N/A
-4.13%		N/A
-29.54%		N/A
-14.23%		N/A
120.84%		N/A
2,272.40%		N/A
-64.36%		N/A
65.82%
Operating Margin
INTS operating margin by date.INTS operating margin by date.
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EPS
YoY % growth
INTS eps by date.INTS eps by date.
N/AN/AN/AN/A-1.17
11.08%		N/A
56.85%		N/A
34.68%		N/A
-7.22%		N/A
30.77%		N/A
116.67%		N/A
1,600.00%		N/AN/A

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q3 / 25 Q4 / 25 Q1 / 26 Q2 / 26
EPS
Q2Q % growth		-0.09
64.30%		-0.08
61.75%		-0.06
72.18%		-0.06
52.92%
Revenue
Q2Q % growth
EBITDA
Q2Q % growth		N/AN/AN/AN/A
EBIT
Q2Q % growth		-2.79M
21.85%		-3.101M
3.18%		-3.142M
7.44%		-3.193M
-18.03%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q2 2025
Q2Q % growth		 -0.13
63.89%		-0.200.0735.47%
Q1 2025
Q2Q % growth		 -0.22
35.29%		-0.20-0.02-10.61%
Q4 2024
Q2Q % growth		 -0.22
-83.33%		-0.230.013.71%
Q3 2024
Q2Q % growth		 -0.25
-47.06%		-0.310.0619.64%
Q2 2024
Q2Q % growth		 -0.36
74.83%		-0.33-0.03-10.29%
Q4 2023
Q2Q % growth		 -0.12 -0.180.0634.64%
Q3 2023
Q2Q % growth		 -0.17 -0.09-0.08-85.19%
Q2 2023
Q2Q % growth		 -1.43 -0.41-1.02-250.49%
INTS Yearly EPS VS EstimatesINTS Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 2027 2028 2029 2030 0 0.5 -0.5 -1
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
INTS Yearly Revenue VS EstimatesINTS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2029 2030 2031 2032 100M 200M 300M 400M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS53.33% 65.46% 35.92% 41.25%
RevenueN/A N/A N/A N/A